SinoMab BioScience Limited

SEHK:3681 Stok Raporu

Piyasa değeri: HK$1.4b

SinoMab BioScience Yönetim

Yönetim kriter kontrolleri 3/4

SinoMab BioScience's CEO is Shawn Leung, appointed in Jan 2001, has a tenure of 23.83 years. total yearly compensation is CN¥5.11M, comprised of 99.7% salary and 0.3% bonuses, including company stock and options. directly owns 11.88% of the company’s shares, worth HK$167.35M. The average tenure of the management team and the board of directors is 3 years and 4.9 years respectively.

Anahtar bilgiler

Shawn Leung

İcra Kurulu Başkanı

CN¥5.1m

Toplam tazminat

CEO maaş yüzdesi99.7%
CEO görev süresi23.8yrs
CEO sahipliği11.9%
Yönetim ortalama görev süresi3yrs
Yönetim Kurulu ortalama görev süresi4.9yrs

Son yönetim güncellemeleri

Recent updates

Update: SinoMab BioScience (HKG:3681) Stock Gained 21% In The Last Year

Mar 04
Update: SinoMab BioScience (HKG:3681) Stock Gained 21% In The Last Year

What You Need To Know About SinoMab BioScience Limited's (HKG:3681) Investor Composition

Jan 28
What You Need To Know About SinoMab BioScience Limited's (HKG:3681) Investor Composition

Did SinoMab BioScience Limited (HKG:3681) Insiders Buy Up More Shares?

Jan 01
Did SinoMab BioScience Limited (HKG:3681) Insiders Buy Up More Shares?

Loss-Making SinoMab BioScience Limited (HKG:3681) Expected To Breakeven In The Medium-Term

Nov 30
Loss-Making SinoMab BioScience Limited (HKG:3681) Expected To Breakeven In The Medium-Term

CEO Tazminat Analizi

Shawn Leung'un ücretlendirmesi SinoMab BioScience'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-CN¥200m

Mar 31 2024n/an/a

-CN¥221m

Dec 31 2023CN¥5mCN¥5m

-CN¥243m

Sep 30 2023n/an/a

-CN¥259m

Jun 30 2023n/an/a

-CN¥274m

Mar 31 2023n/an/a

-CN¥279m

Dec 31 2022CN¥5mCN¥5m

-CN¥284m

Sep 30 2022n/an/a

-CN¥301m

Jun 30 2022n/an/a

-CN¥318m

Mar 31 2022n/an/a

-CN¥303m

Dec 31 2021CN¥4mCN¥4m

-CN¥288m

Sep 30 2021n/an/a

-CN¥222m

Jun 30 2021n/an/a

-CN¥156m

Mar 31 2021n/an/a

-CN¥139m

Dec 31 2020CN¥5mCN¥4m

-CN¥123m

Tazminat ve Piyasa: Shawn's total compensation ($USD719.96K) is above average for companies of similar size in the Hong Kong market ($USD359.95K).

Tazminat ve Kazançlar: Shawn's compensation has been consistent with company performance over the past year.

CEO

Shawn Leung (64 yo)

23.8yrs

Görev süresi

CN¥5,106,000

Tazminat

Dr. Shui On Leung, also known as Shawn, serves as Chief Executive Officer of SinoMab BioScience Limited since January 2003 and also serves as its Director and Chairman of the Board since April 27 2001 and...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Shui On Leung
Founder23.8yrsCN¥5.11m11.88%
HK$ 167.4m
Jianping Hua
Chief Financial Officer5.8yrsVeri yokVeri yok
Yuande Zhang
Director of Marketing1.8yrsVeri yokVeri yok
Lixin Zhang Auberson
Chief Medical Officer3.3yrsVeri yokVeri yok
Shanchun Wang
President of China & Executive Director2.8yrsVeri yok1.19%
HK$ 16.7m
Yuk Yin Chow
Company secretary1.7yrsVeri yokVeri yok

3.0yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim: 3681's management team is considered experienced (3 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Shui On Leung
Founder23.6yrsCN¥5.11m11.88%
HK$ 167.4m
Shanchun Wang
President of China & Executive Directorless than a yearVeri yok1.19%
HK$ 16.7m
Ping Cho Hon
Independent Non-Executive Director5.1yrsCN¥283.00kVeri yok
Haigang Chen
Non-Executive Director7.3yrsVeri yokVeri yok
Dylan Carlo Tinker
Independent Non-Executive Director5.1yrsCN¥283.00kVeri yok
Xun Dong
Non-Executive Director4.9yrsVeri yokVeri yok
George William Hunter Cautherley
Independent Non Executive Director4.9yrsCN¥283.00kVeri yok
Chi Ming Lee
Independent Non-Executive Director3.4yrsCN¥283.00kVeri yok
Lei Shi
Non-Executive Director2.9yrsVeri yokVeri yok
Jianmin Zhang
Non-Executive Director1.2yrsVeri yokVeri yok

4.9yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 3681's board of directors are considered experienced (4.9 years average tenure).